Nicole Déglon

15.1k total citations · 1 hit paper
162 papers, 11.5k citations indexed

About

Nicole Déglon is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Nicole Déglon has authored 162 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Molecular Biology, 102 papers in Cellular and Molecular Neuroscience and 43 papers in Genetics. Recurrent topics in Nicole Déglon's work include Genetic Neurodegenerative Diseases (59 papers), Virus-based gene therapy research (41 papers) and Mitochondrial Function and Pathology (37 papers). Nicole Déglon is often cited by papers focused on Genetic Neurodegenerative Diseases (59 papers), Virus-based gene therapy research (41 papers) and Mitochondrial Function and Pathology (37 papers). Nicole Déglon collaborates with scholars based in Switzerland, France and United States. Nicole Déglon's co-authors include Patrick Aebischer, Philippe Hantraye, Emmanuel Brouillet, Luís Pereira de Almeida, Anne D. Zurn, Noëlle Dufour, Gwennaëlle Aurégan, Jocelyne Bloch, Bernard L. Schneider and Etienne Régulier and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Nicole Déglon

161 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease

2000 1.0k citations Jocelyne Bloch, Philippe Hantraye et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicole Déglon Switzerland	63	6.8k	6.1k	2.3k	2.0k	1.4k	162	11.5k
Albee Messing United States	65	8.8k 1.3×	4.8k 0.8×	1.3k 0.5×	1.7k 0.9×	1.2k 0.9×	174	14.5k
Antonella Consiglio Italy	31	4.9k 0.7×	2.5k 0.4×	1.8k 0.8×	1.0k 0.5×	1.8k 1.3×	57	8.9k
Veerle Baekelandt Belgium	58	5.3k 0.8×	3.4k 0.5×	4.7k 2.0×	1.0k 0.5×	2.7k 2.0×	218	11.7k
Elena Cattaneo Italy	66	12.7k 1.9×	9.8k 1.6×	3.1k 1.3×	1.4k 0.7×	2.0k 1.4×	218	19.2k
R. Jeroen Pasterkamp Netherlands	55	5.1k 0.8×	4.9k 0.8×	2.2k 1.0×	705 0.3×	840 0.6×	166	11.1k
Xiao‐Jiang Li United States	54	8.0k 1.2×	7.0k 1.1×	2.5k 1.1×	797 0.4×	886 0.6×	154	10.7k
Alun M. Davies United Kingdom	69	6.5k 1.0×	9.7k 1.6×	1.3k 0.6×	937 0.5×	1.6k 1.2×	190	15.5k
Christopher E. Henderson France	51	7.1k 1.0×	5.7k 0.9×	2.3k 1.0×	802 0.4×	1.2k 0.8×	129	13.5k
Bernard L. Schneider Switzerland	54	3.5k 0.5×	3.2k 0.5×	2.9k 1.3×	725 0.4×	1.7k 1.2×	150	8.9k
Brian K. Kaspar United States	54	7.3k 1.1×	2.6k 0.4×	2.9k 1.3×	3.3k 1.6×	1.4k 1.0×	122	12.4k

Countries citing papers authored by Nicole Déglon

Since Specialization

Citations

This map shows the geographic impact of Nicole Déglon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Déglon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Déglon more than expected).

Fields of papers citing papers by Nicole Déglon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Déglon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Déglon. The network helps show where Nicole Déglon may publish in the future.

Co-authorship network of co-authors of Nicole Déglon

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Déglon. A scholar is included among the top collaborators of Nicole Déglon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Déglon. Nicole Déglon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rey, María, et al.. (2023). Semi-automated workflows to quantify AAV transduction in various brain areas and predict gene editing outcome for neurological disorders. Molecular Therapy — Methods & Clinical Development. 29. 254–270. 4 indexed citations

Perbet, Romain, Sylvain Perriot, Renaud Du Pasquier, et al.. (2023). Tau Transfer via Extracellular Vesicles Disturbs the Astrocytic Mitochondrial System. Cells. 12(7). 985–985. 17 indexed citations

Schorge, Stéphanie, et al.. (2022). Central Nervous System Gene Therapy: Present Developments and Emerging Trends Accelerating Industry-Academia Pathways. Human Gene Therapy. 33(17-18). 913–922. 2 indexed citations

Hirbec, Hélène, Nicole Déglon, Lynette C. Foo, et al.. (2020). Emerging technologies to study glial cells. Glia. 68(9). 1692–1728. 32 indexed citations

Mérienne, Nicolas, Cécile Meunier, Anne T. Schneider, et al.. (2019). Cell-Type-Specific Gene Expression Profiling in Adult Mouse Brain Reveals Normal and Disease-State Signatures. Cell Reports. 26(9). 2477–2493.e9. 52 indexed citations

Novati, Arianna, Thomas Hentrich, Zinah Wassouf, et al.. (2018). Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease. Scientific Reports. 8(1). 5803–5803. 10 indexed citations

Dujardin, Simon, Séverine Bégard, Raphaëlle Caillierez, et al.. (2018). Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathologica Communications. 6(1). 132–132. 80 indexed citations

Caillierez, Raphaëlle, Séverine Bégard, Katia Lécolle, et al.. (2013). Lentiviral Delivery of the Human Wild-type Tau Protein Mediates a Slow and Progressive Neurodegenerative Tau Pathology in the Rat Brain. Molecular Therapy. 21(7). 1358–1368. 26 indexed citations

Damiano, Maria, Elsa Diguet, Carole Malgorn, et al.. (2013). A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics. 22(19). 3869–3882. 89 indexed citations

10.

Nascimento-Ferreira, Isabel, Tiago Santos‐Ferreira, Lígia Sousa-Ferreira, et al.. (2011). Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado–Joseph disease. Brain. 134(5). 1400–1415. 162 indexed citations

11.

Faideau, Mathilde, Jae-Hwan Kim, Kerry Cormier, et al.. (2010). In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Human Molecular Genetics. 19(15). 3053–3067. 250 indexed citations

12.

Leriche, Ludovic, Tomas Björklund, Nathalie Breysse, et al.. (2009). Positron Emission Tomography Imaging Demonstrates Correlation between Behavioral Recovery and Correction of Dopamine Neurotransmission after Gene Therapy. Journal of Neuroscience. 29(5). 1544–1553. 28 indexed citations

13.

Damiano, Maria, Laurie Galvan, Nicole Déglon, & Emmanuel Brouillet. (2009). Mitochondria in Huntington's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(1). 52–61. 220 indexed citations

14.

Drouet, Valérie, Valérie Perrin, Raymonde Hässig, et al.. (2008). Effects of long-term and global huntingtin silencing. Human Gene Therapy. 19(10). 1125–1126. 1 indexed citations

15.

Benchoua, Alexandra, Yaël Trioulier, Elsa Diguet, et al.. (2008). Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. Human Molecular Genetics. 17(10). 1446–1456. 54 indexed citations

16.

Escartin, Carole, Karin Pierre, Emmanuel Brouillet, et al.. (2007). Activation of Astrocytes by CNTF Induces Metabolic Plasticity and Increases Resistance to Metabolic Insults. Journal of Neuroscience. 27(27). 7094–7104. 104 indexed citations

17.

Escartin, Carole, Emmanuel Brouillet, Paolo Gubellini, et al.. (2006). Ciliary Neurotrophic Factor Activates Astrocytes, Redistributes Their Glutamate Transporters GLAST and GLT-1 to Raft Microdomains, and Improves Glutamate HandlingIn Vivo. Journal of Neuroscience. 26(22). 5978–5989. 75 indexed citations

18.

Déglon, Nicole, et al.. (2003). Presence of Gal‐α1,3Gal epitope on xenogeneic lines: implications for cellular gene therapy based on the encapsulation technology. Xenotransplantation. 10(3). 204–213. 7 indexed citations

19.

Arsenijévic, Yvan, Jean-Guy Villemure, Jean‐François Brunet, et al.. (2001). Isolation of Multipotent Neural Precursors Residing in the Cortex of the Adult Human Brain. Experimental Neurology. 170(1). 48–62. 241 indexed citations

20.

Fasel, Nicolás, et al.. (1992). Membrane μ poly(A) signal and 3′ flanking sequences function as a transcription terminator for immunoglobulin-encoding genes. Gene. 122(2). 297–304. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact